SEPPRO
Live / Registered — Registered and renewed (as of 22 Sept 2015)
What this means for you
Registered since 18 Oct 2005. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 18 Oct 2015).
Record
- Serial number
- 78359775
- Registration number
- 3007344
- Mark type
- Stylized text
- Filed
- 29 Jan 2004
- Published for opposition
- 26 Jul 2005
- Registered
- 18 Oct 2005
- Next maintenance due
- 18 Oct 2015
- Attorney of record
- William C. Wright
Goods and services
- Class 001 — Chemicals: Reagents for fractionating target proteins from complex biological fluids, such as plasma, serum, CSF, urine or other tissue or cellular sources, and the subsequent chemical analysis of compounds physiologically associated with abundant proteins including proteins, peptides, fatty acids, hormones, glycosylation states, phosphorylation states, etc; Reagents for diagnosis of diseases associated with albumin, IgG, Fibrinogen, Transferrin, IgA, IgM, a2-Macroglobulin, a1-Acid Glycoprotein, a1-Antitrypsin, Haptoglobin, High Density Lipoproteins, Complement C3; Immunoaffinity reagents for developing chemical markers that indicate the presence of disease states associated with albumin, IgG, Fibrinogen, Transferrin, IgA, IgM, a2-Macroglobulin, a1-Acid Glycoprotein, a1-Antitrypsin, Haptoglobin, High Density Lipoproteins, Complement C3; Reagents for determining biological targets for drugs, namely determining biological processes that are susceptible to being affected by drugs in order that the drugs may alleviate disease states and conditions related to albumin, IgG, Fibrinogen, Transferrin, IgA, IgM, a2-Macroglobulin, a1-Acid Glycoprotein, a1-Antitrypsin, Haptoglobin, High Density Lipoproteins, Complement C3 and associated compounds in humans and animals; Reagents for determining protein and peptide sequences for the purposes of identifying protein or peptide drug targets associated with albumin, IgG, Fibrinogen, Transferrin, IgA, IgM, a2-Macroglobulin, a1-Acid Glycoprotein, a1-Antitrypsin, Haptoglobin, High Density Lipoproteins, Complement C3, all for research use
- Class 042 — Scientific and technological services: Product development, medical and laboratory research in the field of proteomics, namely the science, system, components, organization, function, and biomedical applications of separation of abundant proteins, especially, in the area of proteomics sample processing that permits highly selective separation of abundant proteins, such as albumin, IgG, Fibrinogen, Transferrin, IgA, IgM, a2-Macroglobulin, a1-Acid Glycoprotein, a1-Antitrypsin, Haptoglobin, High Density Lipoproteins, Complement C3; development of chemical markers that indicate the presence of disease states; determining biological targets for drugs, namely determining biological processes that are susceptible to being affected by drugs in order that the drugs may alleviate disease states and conditions in humans and animals; determining protein and peptide sequences for the purposes of identifying protein or peptide drug targets; developing methodologies relating to the previous services such as developing bioanalytical methods to increase sensitivity, specificity and throughput of identifying and characterizing biological substances such as protein, peptides, hormones, lipids, used as biomarkers for a diagnosis or as drug targets
Owner
- MERCK KGAA, DARMSTADT, DE
- SIGMA-ALDRICH CO., LLC, ST. LOUIS, MO, US
- SIGMA-ALDRICH BIOTECHNOLOGY L.P., ST. LOUIS, MO, US
- GenWay Biotech, Inc., San Diego, CA, US
- GenWay Biotech, Inc., San Diego, CA, US
- GenWay Biotech, Inc., San Diego, CA, US
Prosecution history
- 18 Oct 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 20 May 2021 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 20 May 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 May 2021 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 20 May 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 20 May 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 20 May 2021 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 28 Oct 2020 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 22 Sept 2015 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 22 Sept 2015 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 22 Sept 2015 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 22 Sept 2015 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 24 Aug 2015 — TEAS SECTION 8 & 9 RECEIVED
- 24 Aug 2015 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 21 Apr 2012 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED